Literature DB >> 22167000

Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Hanno Matthaei1, Alexis L Norris, Athanasios C Tsiatis, Kelly Olino, Seung-Mo Hong, Marco dal Molin, Michael G Goggins, Marcia Canto, Karen M Horton, Keith D Jackson, Paola Capelli, Giuseppe Zamboni, Laura Bortesi, Toru Furukawa, Shinichi Egawa, Masaharu Ishida, Shigeru Ottomo, Michiaki Unno, Fuyuhiko Motoi, Christopher L Wolfgang, Barish H Edil, John L Cameron, James R Eshleman, Richard D Schulick, Anirban Maitra, Ralph H Hruban.   

Abstract

OBJECTIVE: To examine the clinicopathologic features and clonal relationship of multifocal intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
BACKGROUND: Intraductal papillary mucinous neoplasms are increasingly diagnosed cystic precursor lesions of pancreatic cancer. Intraductal papillary mucinous neoplasms can be multifocal and a potential cause of recurrence after partial pancreatectomy.
METHODS: Thirty four patients with histologically documented multifocal IPMNs were collected and their clinicopathologic features catalogued. In addition, thirty multifocal IPMNs arising in 13 patients from 3 hospitals were subjected to laser microdissection followed by KRAS pyrosequencing and loss of heterozygosity (LOH) analysis on chromosomes 6q and 17p. Finally, we sought to assess the clonal relationships among multifocal IPMNs.
RESULTS: We identified 34 patients with histologically documented multifocal IPMNs. Synchronous IPMNs were present in 29 patients (85%), whereas 5 (15%) developed clinically significant metachronous IPMNs. Six patients (18%) had a history of familial pancreatic cancer. A majority of multifocal IPMNs (86% synchronous, 100% metachronous) were composed of branch duct lesions, and typically demonstrated a gastric-foveolar subtype epithelium with low or intermediate grades of dysplasia. Three synchronous IPMNs (10%) had an associated invasive cancer. Molecular analysis of multiple IPMNs from 13 patients demonstrated nonoverlapping KRAS gene mutations in 8 patients (62%) and discordant LOH profiles in 7 patients (54%); independent genetic alterations were established in 9 of the 13 patients (69%).
CONCLUSIONS: The majority of multifocal IPMNs arise independently and exhibit a gastric-foveolar subtype, with low to intermediate dysplasia. These findings underscore the importance of life-long follow-up after resection for an IPMN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22167000      PMCID: PMC3534752          DOI: 10.1097/SLA.0b013e3182378a18

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis.

Authors:  Jordan M Winter; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; David Chang; Taylor S Riall; Joann Coleman; Patricia K Sauter; Marcia Canto; Ralph H Hruban; Richard D Schulick; Michael A Choti; Charles J Yeo
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?

Authors:  Claudio Bassi; Stefano Crippa; Roberto Salvia
Journal:  Gut       Date:  2008-03       Impact factor: 23.059

3.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management.

Authors:  M Kobari; S Egawa; K Shibuya; H Shimamura; M Sunamura; K Takeda; S Matsuno; T Furukawa
Journal:  Arch Surg       Date:  1999-10

5.  BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.

Authors:  Frank Schönleben; Wanglong Qiu; Karl C Bruckman; Nancy T Ciau; Xiaojun Li; Margaret H Lauerman; Harold Frucht; John A Chabot; John D Allendorf; Helen E Remotti; Gloria H Su
Journal:  Cancer Lett       Date:  2006-11-09       Impact factor: 8.679

Review 6.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

7.  in vitro biological evaluation of folate-functionalized block copolymer micelles for selective anti-cancer drug delivery.

Authors:  Mariano Licciardi; Emanuela F Craparo; Gaetano Giammona; Steven P Armes; Yiqing Tang; Andrew L Lewis
Journal:  Macromol Biosci       Date:  2008-07-07       Impact factor: 4.979

8.  Multifocal branch-duct pancreatic intraductal papillary mucinous neoplasms.

Authors:  Yoshitsugu Tajima; Tamotsu Kuroki; Noritsugu Tsuneoka; Amane Kitasato; Tomohiko Adachi; Takehiro Mishima; Taiichiro Kosaka; Takashi Kanematsu
Journal:  Am J Surg       Date:  2008-05-29       Impact factor: 2.565

9.  Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.

Authors:  Stefan Fritz; Carlos Fernandez-del Castillo; Mari Mino-Kenudson; Stefano Crippa; Vikram Deshpande; Gregory Y Lauwers; Andrew L Warshaw; Sarah P Thayer; A John Iafrate
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  39 in total

1.  Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.

Authors:  Antonio Pea; Jun Yu; Neda Rezaee; Claudio Luchini; Jin He; Marco Dal Molin; James F Griffin; Helen Fedor; Shahriar Fesharakizadeh; Roberto Salvia; Matthew J Weiss; Claudio Bassi; John L Cameron; Lei Zheng; Aldo Scarpa; Ralph H Hruban; Anne Marie Lennon; Michael Goggins; Christopher L Wolfgang; Laura D Wood
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

Review 2.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 3.  Pancreatic cancer from bench to bedside: molecular pathways and treatment options.

Authors:  Christoforos Kosmidis; Konstantinos Sapalidis; Efstathios Kotidis; Nikolaos Mixalopoulos; Paul Zarogoulidis; Drosos Tsavlis; Sofia Baka; Yan-Gao Man; John Kanellos
Journal:  Ann Transl Med       Date:  2016-05

4.  The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.

Authors:  Guido von Figura; Akihisa Fukuda; Nilotpal Roy; Muluye E Liku; John P Morris Iv; Grace E Kim; Holger A Russ; Matthew A Firpo; Sean J Mulvihill; David W Dawson; Jorge Ferrer; William F Mueller; Anke Busch; Klemens J Hertel; Matthias Hebrok
Journal:  Nat Cell Biol       Date:  2014-02-23       Impact factor: 28.824

Review 5.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life.

Authors:  Yusuke Watanabe; Takao Ohtsuka; Taketo Matsunaga; Hideyo Kimura; Koji Tamura; Noboru Ideno; Teppei Aso; Yoshihiro Miyasaka; Junji Ueda; Shunichi Takahata; Hisato Igarashi; Toyoshi Inoguchi; Tetsuhide Ito; Masao Tanaka
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

7.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 8.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

9.  GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Authors:  Hanno Matthaei; Jian Wu; Marco Dal Molin; Chanjuan Shi; Sven Perner; Glen Kristiansen; Philipp Lingohr; Jörg C Kalff; Christopher L Wolfgang; Kenneth W Kinzler; Bert Vogelstein; Anirban Maitra; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

10.  One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.

Authors:  Tatsuo Hata; Naoaki Sakata; Fuyuhiko Motoi; Michiaki Unno
Journal:  BMJ Case Rep       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.